After 4 years with blood donation mobilization and blood component production, we obtain encouraging results, as following: 1. Renovation on blood donor source, from 90% of professional donor in 1993, down to 53% in 1997. 2. Blood collection volume is increased 3 times in 1997 in comparison to the collection in 1993. 3. Blood transfusion is ensured to be safer than in the past, by systemic application of screening test of HBV, HCV and HIV. Through screening, we detected thousands peoples with positive HBsAg, hundreds of positive anti HCV and anti HIV. These take an important part to ensure blood transfusion safety. 4. It is separated into 4 basic blood components, with packed red cell, platelet concentrated, frozen fresh plasma and cryoprecipitate. 5. It takes about 70% of partial blood transfusion among total blood transfused in 1997, compared to less than 10% before year’s 1994. Obviously, blood donation mobilization takes benefit not only for treatment service, but also for blood transfusion safety and people health care with high economic value.
Blood Donors ; Metabolism ; Blood

During 5 years period(1994-1998) blood donor motivation and blood component preparation, encouraging results have been achieved: 1. Renew of blood resources with 90% of donors was professional in 1993 changed to 53% and 37% in 1997 and 1998, respectively. 2. Blood collection volume per year raised 4 times in comparing with the data in 1993 (800 litres to 2,850 litres in 1998). 3. 1,000 of donors with HBsAg(+) and 100 of donors with anti-HCV(+) and anti-HIV(-) have been excluded by screening. 4. 4 basic blood component have been prepared including red cell concentrates, platelet concentrates, fresh frozen plasma and anti haemophilia A cryoprecipitates. 5. 70% of clinical transfusion carried out with blood components and blood transfusion reaction have been decreasing. 6. Obviously, blood donor motivation gave a lot of advantage to patient treatment, blood transfusion safety, health care system with better economic effectiveness.
Blood Donors ; metabolism ; Blood

Human blood platelets play an important role in a variety of basic life processes, and are widely involved in various biological processes in the human body, including inflammation, wound healing and thrombosis etc. As unnuclear cell particles, platelets do not lend themselves to analysis by traditional cell and molecular biology techniques. In contrast, the study of proteomics and the protein complement of a genome will have a major impact on platelet biology. Moreover, platelet proteomics has been used to analyze a variety of complex biological processes in platelet proteome. This article will review the latest progress on platelet proteomics research, such as the proteomics and its related techniques, proteomics associated with platelets (static and activated platelet proteomics, platelet microparticle proteomics, platelet membrane proteomics, platelet phosphorylation proteomics) as well as platelet proteomics and diseases.
Blood Platelets ; metabolism ; Humans ; Proteomics

The change in serum laminin (LN) level and its clinical significance in epithelial ovarian tumor were investigated. The LN levels in serum and ascites samples from 69 patients with epithelial ovarian tumor and 42 cases as control group before and after operation were analyzed by radioimmunoassay. The results showed that the serum LN levels in the patients with malignant tumors (157.85 +/- 14.37 ng/ml) were significantly higher than that in the control group (125.14 +/- 7.03 ng/ml) and in the patients with benign tumors (128.36 +/- 8.75 ng/ml) (both P < 0.01) before operation. The serum LN levels in the malignant group were decreased significantly after operation as compared with those before operation (P < 0.05). The serum LN levels in low-differentiated tumors was higher than those in moderate-differentiated tumors and high-differentiated tumors (P < 0.05). The LN levels in ascites (172.94 +/- 15.26 ng/ml) was significantly higher than in serum (161.34 +/- 6.59 ng/ml) (P < 0.05) in malignant tumors. The serum LN levels in the patients with lymph node metastasis (165.41 +/- 19.91 ng/ml) was obviously higher than those without lymph node metastasis (152.35 +/- 10.34 ng/ml) (P < 0.05). It was concluded that LN levels in serum and acistis were remarkably increased in malignant epithelial ovarian tumors, suggesting that LN might be one of important diameters reflecting tumor biological characteristics.
Ascitic Fluid ; metabolism ; Biomarkers, Tumor ; blood ; metabolism ; Carcinoma ; blood ; metabolism ; Female ; Humans ; Laminin ; blood ; metabolism ; Male ; Ovarian Neoplasms ; metabolism

BACKGROUNDPrevious studies reported interleukin-27 (IL-27), interferon-γ (IFN-γ), or adenosine deaminase (ADA) alone plays a helpful role in diagnosing tuberculous pleural effusion (TPE). The present study aims at comparing the diagnostic accuracy of pleural IL-27, IFN-γ, and ADA, and investigate the diagnostic accuracy of the combination of IL-27, IFN-γ, or/and ADA for differentiating TPE from pleural effusions with the other etiologies.

METHODSThe concentrations of IL-27, IFN-γ and ADA were simultaneously determined in pleural fluids and sera from 40 patients with TPE; 26 with malignant pleural effusion, seven with infectious pleural effusion, and eight with transudative pleural effusion by enzyme linked immunosorbent assay and colorimetric method. The corresponding biochemical indexs were also simultaneously determined.

RESULTSThe concentrations of pleural IL-27 and IFN-γ in the tuberculous group were significantly higher than those in the malignant, infectious, and transudative groups. The concentrations of ADA in TPE were significantly higher than those in MPE or transudative effusions, while much lower than those in infectious effusions. Among these three biomarkers, IL-27 was the most effective for TPE diagnosis, with the cut off value of 900.8 ng/L. IL-27 had a high sensitivity of 95% and specificity of 97.6% for differential diagnosis of TPE from non-TPEs. Combinations of IL-27, IFN-γ and ADA measurements further increased the sensitivity or specificity up to 100%.

CONCLUSIONSCompared to non-TPEs, IL-27, IFN-γ and ADA all simultaneously increased in TPE; and among these three rapid detection methods, IL-27 appeared to be the best for distinguishing tuberculous from non-TPEs, especially from MPE. Combinations of the three markers (IL-27, IFN-γ and ADA) yielded the highest sensitivity and specificity. These findings suggest that the applications of a new biomarker, IL-27, alone or with IFN-γ and ADA, may contribute to more efficient diagnosis strategies in the management of tuberculous pleurisy.

Adenosine Deaminase ; blood ; metabolism ; Aged ; Female ; Humans ; Interferon-gamma ; blood ; metabolism ; Interleukin-27 ; blood ; metabolism ; Male ; Middle Aged ; Pleural Effusion ; blood ; metabolism ; Tuberculosis, Pleural ; blood ; diagnosis ; metabolism

Chemokine is a class of soluble active peptides that attract white blood cells to the inflammatory site. CD40 ligand (CD40L) involves in synthesis of proinflammatory mediators. Accumulation of chemokine and CD40L can induce non-hemolytic reaction after transfusion, transfusion-related acute lung injury (TRALI) and autoimmune disease during blood component storage. Pre-storage leucocyte deletion can prevent the release of leucocyte-derived chemokines, but not prevent the accumulation of platelet-derived chemokines. γ-irradiation or ultraviolet β irradiation is effective in preventing the increase of chemokines in the storage of platelet, thus prevents non-hemolytic febrile reaction after platelet transfusion. In this review, the recent advance in research of accumulation of chemokines and CD40L during blood component storage, and its effect on blood transfusion, as well as preventive measures are summarized.
Blood Platelets ; metabolism ; Blood Preservation ; Blood Transfusion ; CD40 Ligand ; blood ; Chemokines ; blood ; Humans

BACKGROUNDEarly detection and diagnosis is urgent for the sake of effective treatment strategy for lung cancer. However, a convenient, economical and relatively precise method is not available. We here report a prospective study to find the possible value of the combined use of four popular tumor markers in the early diagnosis of lung cancer among patients with suspicious nodules in the lung.

METHODSSix hundred and sixty inpatients with suspicious nodules in the lung were divided into a lung cancer group and a benign pulmonary tumor group according to post-operative histological examinations. Serum levels of four tumor markers including squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), Cyfra 21-1 and neuron specific enolase (NSE) were assayed for each patient. Receiver operating characteristic (ROC) curves were constructed for each tumor marker. The power of lung cancer diagnosis of each tumor marker, as well as a combination of them were analyzed and compared.

RESULTSThe serum levels (median, range) of SCC, CEA, Cyfra 21-1 and NSE were 0.44 (0.01 - 35.70) ng/ml, 2.49 (0.30 - 26.78) ng/ml, 2.30 (0.82 - 73.33) ng/ml and 10.54 (0.10 - 56.41) ng/ml respectively in lung cancer group, and were 0.32 (0.01 - 0.90) ng/ml, 1.60 (0.20 - 8.93) ng/ml, 1.41 (0.72 - 4.82) ng/ml and 9.36 (6.56 - 24.24) ng/ml respectively in the benign pulmonary tumor group. The difference in each tumor marker between the two groups was significant (P < 0.05). The ROCs of SCC, CEA, Cyfra 21-1 and NSE were 0.702 (95%CI, 0.654 - 0.751), 0.611 (95%CI, 0.563 - 0.659), 0.650 (95%CI, 0.601 - 0.700) and 0.598 (95%CI, 0.542 - 0.654) respectively, indicating very low power of these four tumor markers. When a combination of SCC, CEA, Cyfra 21-1 and NSE were employed, the diagnosis power was strengthened.

CONCLUSIONSCC, CEA, Cyfra 21-1 and NSE are valuable in the early diagnosis of lung cancer among suspicious nodules in the lung, especially when they were assayed together for one patient.

Aged ; Antigens, Neoplasm ; blood ; metabolism ; Biomarkers, Tumor ; blood ; metabolism ; Carcinoembryonic Antigen ; blood ; metabolism ; Female ; Humans ; Keratin-19 ; blood ; metabolism ; Lung Neoplasms ; blood ; metabolism ; Male ; Middle Aged ; Phosphopyruvate Hydratase ; blood ; metabolism ; Serpins ; blood ; metabolism

Ascites ; metabolism ; Carcinoma, Hepatocellular ; blood ; metabolism ; pathology ; Chemokine CCL2 ; blood ; metabolism ; Hepatitis B, Chronic ; blood ; metabolism ; Humans ; Immunohistochemistry ; Liver ; metabolism ; pathology ; Liver Cirrhosis ; blood ; metabolism ; pathology ; Liver Neoplasms ; blood ; metabolism ; pathology ; Receptors, CCR2 ; blood ; metabolism

OBJECTIVETo investigate the changes of angiotensin II (Ang II) and its receptors in male rats with diabetic erectile dysfunction (DED) so as to study its effects.

METHODSOut of 40 male SD rats, 30 were taken at random for diabetic models. After 8 weeks, the rats with erectile dysfunction were selected from these models. All the rats were divided into 3 groups: control ( n = 10), diabetes mellitus( DM, n = 9) and DED (n = 8). For each rat, the Ang II levels in the blood and homogenate prepared from part of the isolated penile tissues were determined respectively, and the Ang II receptors of the rest of the penile tissues were analyzed through immunohistochemical (IHC) assay.

RESULTSCompared with the control group, Ang II levels in the blood and penile tissues in the DM group, and that in the blood of the DED group were very high and the differences were statistically significant (P < 0.05). Ang II in the penile tissues of the DED increased sharply (P < 0.01). The receptors of Ang II changed contrariwise to the level of Ang ll.

CONCLUSIONAng II may play an important role in the pathogenesis of DED, and the Ang II antagonist or inhibitor of the angiotensin-converting enzyme (ACEI) may become a therapeutic method for DED in the future.

Angiotensin II ; blood ; metabolism ; Animals ; Diabetes Complications ; blood ; metabolism ; Erectile Dysfunction ; blood ; etiology ; metabolism ; Immunohistochemistry ; Male ; Penis ; metabolism ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptors, Angiotensin ; blood ; metabolism

OBJECTIVE: To investigate the effect of IL-17 and IL-23 in the pathogenesis of allergic rhinitis(AR) and non. allergic rhinitis(NAR). METHOD: Selected 156 cases of patients with allergic rhinitis (AR group) and 59 cases of patients with non-allergic rhinitis (NAR group), 60 cases of healthy people (control group). All cases in AR group and NAR groups were evaluated by a visual analog scale (VAS) score of nasal symptoms. Collected peripheral blood and nasal secretions in all cases and then detected IL-17 and IL-23 expression levels. RESULT: There was no significant difference in VAS score of AR group and NAR group (P>0. 05). IL-17 and IL-23 levels of serum and nasal secretions in AR group and NAR group were both higher than control group, with a highly significant difference (P <0. 05). The research showed a clear correlation between expression of IL-17 and IL-23 both in serum and nasal secretions of AR group and NAR(P<0. 05). CONCLUSION IL-17 and IL-23 may be important cytokines and IL-23/IL-17 pathway may play a significant role in the pathogenesis of allergic rhinitis and non-allergic rhinitis.
Case-Control Studies ; Humans ; Interleukin-17 ; blood ; metabolism ; Interleukin-23 ; blood ; metabolism ; Nasal Mucosa ; metabolism ; Rhinitis ; blood ; metabolism ; Rhinitis, Allergic ; blood ; metabolism